文献速递中医内科中药与中成药合理使用

马兜铃酸与2型糖尿病患者癌症风险的全国性队列研究

Aristolochic acid and the risk of cancers in patients with type 2 diabetes: Nationwide population-based cohort study.
PubMed 文献 · Phytomedicine · 2022-03-03

该研究利用台湾全民健康保险研究数据库,纳入1997-2010年确诊的2型糖尿病患者,追踪含马兜铃酸中药使用与1997-2013年癌症发生的关系。结果显示,马兜铃酸暴露与肝癌、结直肠癌、肾癌、膀胱癌、前列腺癌、肾盂癌和输尿管癌风险呈剂量依赖性升高,女性中高剂量暴露还与非肝外胆管癌风险升高相关。

要点

  • 马兜铃酸暴露与多种泌尿及消化系统癌症风险升高相关。
  • 风险随马兜铃酸累积剂量增加而升高,呈剂量依赖性。
  • 女性高剂量马兜铃酸暴露需警惕肝外胆管癌风险。

核心结论

  • 马兜铃酸暴露可能增加2型糖尿病患者肾癌、膀胱癌、肾盂癌、输尿管癌、肝癌、结直肠癌和前列腺癌风险,女性中高剂量暴露还与非肝外胆管癌风险升高相关。

研究设计与样本

  • 基于台湾全民健康保险研究数据库的全国性队列研究,纳入1997-2010年确诊的18岁以上2型糖尿病患者,追踪至2013年。

主要发现

  • 含马兜铃酸中药使用与肝癌、结直肠癌、肾癌、膀胱癌、前列腺癌、肾盂癌和输尿管癌风险显著升高相关,且呈剂量依赖性。
  • 女性中马兜铃酸暴露剂量超过500 mg时,肝外胆管癌风险升高。

关键数值与推荐

  • 女性马兜铃酸暴露剂量超过500 mg与肝外胆管癌风险升高相关。

临床怎么用

  • 临床应严格避免含马兜铃酸中药的处方与使用,尤其对2型糖尿病患者需加强用药史筛查与癌症监测。
  • 对曾有马兜铃酸暴露史的患者,应关注泌尿系统及消化系统癌症的早期筛查。

局限性

  • 原文未报告具体局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Both aristolochic acid (AA) exposure and diabetic can increase risk of certain cancers,whetherAAexposureincreases cancer risk in diabetic patientsisunknown. The purpose of this study was to investigate the association between the use of Chinese herbal products containing AA and the risk of cancer in diabetic patients. METHODS: A cohort study was conducted using the National Health Insurance Research Database in Taiwan. Patients older than 18 years who were diagnosed with diabetes between 1997 and 2010 were enrolled in our cohort. The use of Chinese herbal products containing AA was recorded from the beginning of 1997 until the ban of herbs containing AA in November 2003. Patients were individually tracked to identify cancer incidence between 1997 and 2013. Only patients who visited traditional Chinese medicine clinics between 1997 and 1 year before the end of follow-up were included in the cohort to ensure comparability. Cox proportional hazards regression was used to calculate the hazard ratio for the association between the use of Chinese herbal products containing AA and the occurrence of cancer. RESULTS: Among the 430 377 male and 431 956 female patients with diabetes enrolled in our cohort, 37 554 and 31 535 cancer diagnoses were recorded during the study period, respectively. The use of AA-containing herbal products was associated with a significantly higher risk of liver, colorectum, kidney, bladder, prostate, pelvis, and ureter cancer in a dose-dependent manner. An increased risk of extrahepatic bile duct cancer in women was also associated with AA exposure at doses of more than 500 mg. CONCLUSIONS: Association between AA exposure and the risk of some cancers were found in this study. AA exposure might increase risk of kidney,bladder,pelvis, ureter,liver,colorectum,andprostatecancer in all patientsandextrahepatic bile duct cancerin women.

来源:Phytomedicine,查看原文。版权归原作者所有。

引用

  1. Chen CJ, Chiu WC, Tseng YH, et al. Aristolochic acid and the risk of cancers in patients with type 2 diabetes: Nationwide population-based cohort study. Phytomedicine. 2022. PMID: 35276591. doi:10.1016/j.phymed.2022.154023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。